Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trials - ARAMILAB Access content directly
Conference Papers Year : 2017

Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trials

Fichier principal
Vignette du fichier
Ansart et al_hal.pdf (174.07 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02098434 , version 1 (12-04-2019)
hal-02098434 , version 2 (12-04-2019)

Identifiers

  • HAL Id : hal-02098434 , version 1

Cite

Manon Ansart, Stéphane Epelbaum, Olivier Colliot, Didier Dormont, Bruno Dubois, et al.. Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trials. Clinical Trials for Alzheimer's Disease, Nov 2017, Boston, United States. ⟨hal-02098434v1⟩

Collections

UPMC ARAMILAB
103 View
145 Download

Share

Gmail Facebook X LinkedIn More